Institute for Clinical Research Official Portal

Clinical Research Centre

Hospital Putrajaya

WhoWe Are

The Clinical Research Center Hospital Putrajaya (CRC HPJ) was established in December 2010 as a clinical research organization under the Ministry of Health Malaysia, under the auspices of the Institute for Clinical Research (ICR), National Institute of Health Malaysia. The functions of this unit are to coordinate research at Putrajaya Hospital, including clinical trials, conduct high-quality and ethical clinical research, run research-related courses, and assist researchers from various backgrounds with their studies by providing technical support and research consultation. This service is available to the staff of Putrajaya Hospital and the Federal Territory of Kuala Lumpur and Putrajaya Health Department (JKWPKL&P). The unit is equipped with facilities such as a discussion room, two clinical examination rooms, a mini laboratory, an Investigational Product room, and a records room.

OurTeam

NAME POSITION QUALIFICATION EMAIL
Dr. Nurain Mohd Noor
Head, Consultant Endocrinologist MBBS, MMed
ppnurain@hpj.gov.my 
Dr. Tong Chin Voon  Deputy Head, Consultant Endocrinologist MD, FRCP tchinvoon@yahoo.com 
Dr. Rashidah Bahari Medical Officer (Admin Manager) MBBS shidahjannah@gmail.com 
Dr. Lisa Mohamed Noor Medical Officer  BMBS lisamdnor.crc@gmail.com 
Dr. Nor Nadziroh Ibrahim Medical Officer  MD nornadziroh@hpj.gov.my 
Dr. Jacelyn Ong Medical Officer  MBBS, MPH (UM) jacelyn386@yahoo.com 
SN Tengku Nor Aiyani Tengku Yusof Staff Nurse Diploma in Nursing tengkunoraiyani@hpj.gov.my 

 

InvestigatorsHighlight

Project Highlights

  NMRR-23-00192-HHB    Effectiveness of A Ramadan-Focused Structured Diabetes Tele-Education in Reducing Diabetes Complications During Ramadan Fasting in Malaysia
  NMRR-21-1918-61166
Extension Study for Safety and Efficacy of Imsidolimab (ANB019) for Generalized Pustular Psoriasis
NMRR-21-1817-61031 A Multicenter Registry of Patients with Generalized Pustular Psoriasis or Palmoplantar Pustulosis
NMRR-22-02077-16T An Extension Study of Long-term Efficacy, Safety & Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies with Remibrutinib
NMRR-19-1258-47901 Semaglutide Cardiovascular Outcomes Trial in Patients with T2DM
NMRR-15-2181-28116 A study Comparing Upadacitinib (ABT-494) to Placebo & Adalimumab in Subjects with moderately to severely Active Rheumatoid Arthritis Who are on Stable / Inadequate Response to Methotrexate
NMRR-19-1290-47661 A Study for Safety & Efficacy of Ertugliflozin in Pediatric Participants Ages 10 to 17 Years with T2DM
NMRR-22-01779-FM3 Efficacy & Safety of CagriSema s.c. 2.4mg/2.4mg Once-weekly in Participants with Overweight or Obesity and T2DM
NMRR-20-1355-55534 Efficacy & Safety of Oral Semaglutide versus Placebo in Combination with Metformin and/or Basal Insulin in Children & Adolescents with T2DM
NMRR-23-01608-6GH A Single Arm Study Investigating the Glycaemic Control and Safety of Adding Semaglutide to Insulin Icodec in Participants with Type 2 Diabetes Qualifying for Treatment Intensification
NMRR-23-00102-WUZ A Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib 25 mg b.i.d. in Comparison to Placebo with Omalizumab 300 mg over in Adult Patients with Chronic Spontaneous Urticaria Inadequately Controlled by Second-Generation H1-Antihistamines
NMRR-23-01937-CT2 An Open-Label Study to Evaluate Efficacy and Safety and the Tmpact of Immunogenicity on Efficacy, Safety, and Pharmacokinetics of Spesolimab i.v. in Treatment of Patients with Generalized Pustular Psoriasis Presenting with a Recurrent Flare following Their Initial GPP Flare Treatment with Spesolimab i.v.
NMRR-23-01915-J4Y An Open-Label, Extension Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults with Growth Hormone Deficiency

List of Publications associated with CRC HPJ

  1. Real-World Evaluation of Care for Type 2 Diabetes in Malaysia: A Cross-Sectional Analysis of the Treatment Adherence to Guideline Evaluation in Type 2 Diabetes (TARGET-T2D) Study
    • Lee-Ling Lim, Zanariah Hussein, Nurain Mohd Noor, Anis S. Abd Raof, Norlaila Mustafa, Mohamed B. Long Bidin, Rohana Abdul Ghani, Syahrizan Samsuddin, Sy-Liang Yong, Siew-Hui Foo, Kavitha Raghuram, Payiarat Suwannasri, Wan Mohamad W. B., Thiam-Kian Chiew, Siew-Pheng Chan
  2. Assessment on Inpatient Glycaemic Control in General Medical Wards, Putrajaya Hospital
    • Nor Nadziroh Ibrahim, Nurain Mohd Noor, Rashidah Bahari, Lisa Mohamed Nor, Nurul Huda Zainal Abidin 

Services at CRC Hospital Putrajaya

CRC HPJ provides training through workshops and consultations:

  • Protocol Development
  • Statistical Analysis
  • NMRR Registration & MREC Approval
  • Grant Application
  • Clinical Data Management 
  • Clinical Research Planning and Coordination
  • Introduction to Clinical Research
  • SPSS training
  • Protocol and Manuscript Writing 
  • Good Clinical Practice (GCP)
  • NMRR Training
  • Technical and administration support in research activities

Counter

IP Storage Room

Mini Lab

Workstation

Equipment Room

Discussion Room

Consultation Room

Record Room

Client 1

CRC Hospital Putrajaya

Clinical Research Centre,
Tingkat 4,
Institut Endokrin,
Hospital Putrajaya,
Presint 7,
62250 Putrajaya
 

Main Phone: +603-80903368

Email: crchpj@gmail.com

 

 

ICR
National Institutes of Health (NIH)
Ministry of Health Malaysia
Institute For Clinical Research
Block B4, National Institutes of Health (NIH)
No.1, Jalan Setia Murni U13/52, Seksyen U13
40170 Shah Alam, Selangor Darul Ehsan
Malaysia
 
Phone: 603-3362 7700
Email: contact@crc.gov.my
 

NIH Official Portal

Client 1

Follow us on